14 
has been suggested that the officer should cover all levels 
of recombinant DNA research. What are the Committee's views 
on recommending that some person or persons be collectively 
responsible for biosafety monitoring of recombinant DNA research 
at the Pi through P3 levels and that a special officer be 
designated with certain responsibilities at the P4 level? 
• It has also been recommended that the biological safety officer 
be a member of an IBC. What are the Committee's views on this 
recommendation? 
Compliance 
• It has been suggested that a section on penalties be included 
in Part IV. Would the Committee object to a compliance section 
that would state that violation of the NIH Guidelines may 
result in suspension, limitation, or termination of NIH grants 
or contracts? 
• It has been suggested that information constituting registration 
of a project with NIH be included in Part IV. Would the Com- 
mittee object to a registration section that would specify 
the basic requirements? 
• As noted previously in the section or. Biological Containment, 
there were many requests for NIH to permit voluntary 
registration and certification by institutions in the private 
sector. Would the Committee object to such a provision? 
• There were a number of suggestions that general policy be 
[515] 
